HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ola Landgren Selected Research

daratumumab

11/2023Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens.
1/2023Final analysis of carfilzomib, dexamethasone, and daratumumab vs carfilzomib and dexamethasone in the CANDOR study.
12/2022A short course of daratumumab in patients with multiple myeloma and minimal residual disease after induction therapy.
1/2022Subgroup analysis based on cytogenetic risk in patients with relapsed or refractory multiple myeloma in the CANDOR study.
1/2022Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): updated outcomes from a randomised, multicentre, open-label, phase 3 study.
6/2021Safety and Effectiveness of Weekly Carfilzomib, Lenalidomide, Dexamethasone, and Daratumumab Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma: The MANHATTAN Nonrandomized Clinical Trial.
5/2021Using MALDI-TOF mass spectrometry in peripheral blood for the follow up of newly diagnosed multiple myeloma patients treated with daratumumab-based combination therapy.
1/2020Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): results from a randomised, multicentre, open-label, phase 3 study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ola Landgren Research Topics

Disease

118Multiple Myeloma
05/2024 - 12/2006
44Neoplasms (Cancer)
05/2024 - 05/2003
25Residual Neoplasm
04/2024 - 07/2013
21Monoclonal Gammopathy of Undetermined Significance
04/2024 - 12/2006
14Smoldering Multiple Myeloma
11/2022 - 02/2014
7B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
02/2022 - 09/2009
7Infections
06/2021 - 12/2007
7Disease Progression
01/2019 - 02/2010
6Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2020 - 04/2009
5Hematologic Neoplasms (Hematological Malignancy)
01/2024 - 01/2006
5Paraproteinemias (Monoclonal Gammopathy)
07/2023 - 10/2011
5Waldenstrom Macroglobulinemia (Macroglobulinemia)
01/2016 - 03/2009
5Lymphoma (Lymphomas)
06/2014 - 03/2007
4Chromothripsis
05/2024 - 07/2023
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2023 - 08/2013
4Lymphoproliferative Disorders (Lymphoproliferative Disorder)
06/2018 - 12/2007
3Hodgkin Disease (Hodgkin's Disease)
01/2020 - 04/2003
3Cardiotoxicity
11/2018 - 03/2015
3Obesity
01/2017 - 11/2012
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
03/2015 - 01/2007
3Acquired Immunodeficiency Syndrome (AIDS)
11/2012 - 05/2010
3Autoimmune Diseases (Autoimmune Disease)
07/2011 - 09/2008
2Cytokine Release Syndrome
01/2024 - 01/2019
2Renal Insufficiency (Renal Failure)
08/2021 - 11/2014
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
08/2021 - 11/2010
2Hypertension (High Blood Pressure)
11/2020 - 06/2020
2COVID-19
11/2020 - 06/2020
2Venous Thrombosis (Deep-Vein Thrombosis)
01/2020 - 11/2008
2Graft vs Host Disease (Graft-Versus-Host Disease)
01/2020 - 02/2016
2Plasma Cell Neoplasms
01/2019 - 05/2010
2Epstein-Barr Virus Infections
06/2018 - 06/2013
2Overweight
01/2017 - 01/2016
2Cardiovascular Diseases (Cardiovascular Disease)
11/2016 - 03/2015
2Celiac Disease (Celiac Sprue)
11/2016 - 03/2015
2Leukemia
11/2016 - 04/2009

Drug/Important Bio-Agent (IBA)

25Dexamethasone (Maxidex)FDA LinkGeneric
11/2023 - 01/2011
24Lenalidomide (CC 5013)FDA Link
11/2023 - 11/2009
24carfilzomibIBA
11/2023 - 09/2015
22Biomarkers (Surrogate Marker)IBA
12/2021 - 12/2010
19Proteins (Proteins, Gene)FDA Link
04/2024 - 06/2010
13Melphalan (Alkeran)FDA LinkGeneric
11/2023 - 11/2009
11Immunoglobulin M (IgM)IBA
04/2024 - 03/2009
8Immunoglobulins (Immunoglobulin)IBA
05/2024 - 03/2005
8Immunoglobulin G (IgG)IBA
04/2024 - 06/2010
8daratumumabIBA
11/2023 - 01/2020
8Bortezomib (Velcade)FDA Link
02/2023 - 11/2009
6Proteasome InhibitorsIBA
06/2021 - 08/2014
6Immunomodulating AgentsIBA
01/2020 - 11/2008
5Immunoglobulin A (IgA)IBA
04/2024 - 06/2010
5Chimeric Antigen ReceptorsIBA
01/2024 - 01/2019
5Monoclonal AntibodiesIBA
12/2023 - 01/2013
5bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
01/2023 - 01/2019
5ORALIT (ORS)IBA
04/2014 - 07/2009
5AntigensIBA
04/2014 - 05/2003
4Interleukin-6 (Interleukin 6)IBA
05/2024 - 12/2012
4DNA (Deoxyribonucleic Acid)IBA
01/2022 - 11/2016
4Proteasome Endopeptidase Complex (Proteasome)IBA
10/2020 - 08/2014
4CytokinesIBA
04/2020 - 10/2011
3Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
05/2024 - 08/2016
3Bispecific AntibodiesIBA
01/2024 - 12/2022
3AntibodiesIBA
11/2023 - 11/2016
3B-Cell Maturation AntigenIBA
01/2023 - 01/2019
3PesticidesIBA
01/2021 - 04/2009
3MicroRNAs (MicroRNA)IBA
01/2020 - 01/2011
3Immunoglobulin Variable RegionIBA
01/2020 - 03/2005
3Doxorubicin (Adriamycin)FDA LinkGeneric
11/2018 - 04/2005
3AdiponectinIBA
01/2017 - 11/2012
3Rituximab (Mabthera)FDA Link
03/2015 - 01/2007
3Thalidomide (Thalomid)FDA Link
01/2013 - 11/2009
3Prednisone (Sone)FDA LinkGeneric
11/2009 - 04/2005
2NF-kappa B (NF-kB)IBA
05/2024 - 07/2023
2Blood Proteins (Serum Proteins)IBA
12/2023 - 12/2021
2RNA (Ribonucleic Acid)IBA
11/2023 - 12/2018
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
11/2023 - 01/2019
2ixazomibIBA
11/2022 - 01/2020
2selinexorIBA
10/2022 - 01/2020
2ibrutinibIBA
02/2022 - 03/2021
2InsecticidesIBA
01/2021 - 11/2015
2HerbicidesIBA
01/2021 - 11/2015
2Permethrin (Ambush)FDA LinkGeneric
01/2021 - 04/2009
2UbiquitinIBA
10/2020 - 08/2014
2ChemokinesIBA
04/2020 - 10/2014
2Agent OrangeIBA
01/2020 - 11/2015
2LigandsIBA
10/2019 - 11/2016
2Cyclin DIBA
04/2017 - 03/2014
2Hormones (Hormone)IBA
01/2017 - 04/2008
2IPH-2101IBA
11/2016 - 06/2014
2Histone Deacetylase InhibitorsIBA
12/2015 - 03/2014

Therapy/Procedure

64Therapeutics
04/2024 - 12/2006
10Immunotherapy
01/2024 - 11/2016
10Drug Therapy (Chemotherapy)
01/2024 - 04/2003
9Stem Cell Transplantation
11/2023 - 11/2009
7Transplantation
01/2020 - 12/2007
4Radiotherapy
08/2021 - 01/2006
4Cell Transplantation
11/2020 - 01/2009
3Hematopoietic Stem Cell Transplantation
01/2020 - 02/2016
3Splenectomy
02/2014 - 01/2006
2Artificial Respiration (Mechanical Ventilation)
11/2020 - 06/2020
2Hematopoietic Stem Cell Mobilization
01/2020 - 01/2017
2Autologous Transplantation
01/2017 - 08/2014